Whitepapers
Explore our whitepapers to gain valuable insights into the key questions within precision medicine and clinical research.
Bridging genes and medicine:
How genetics is redefining patient care
The whitepaper examines how the adoption of genetic information is changing clinical practice by requiring a more personalised approach to healthcare.
Beyond the bench:
The role of patient empowerment in shaping precision medicine research
The whitepaper explores how patient involvement is transforming the field of genomics- and biomarker-driven research.
Collaborative synergy in precision medicine drug development: Bridging academia, biotech, and pharma
The whitepaper examines the dynamic interplay between these critical sectors, outlining the path to innovative treatments and reshaping patient care.
Data-driven healthcare: How artificial intelligence and machine learning are transforming genomics
The whitepaper provides an overview of AI's role in genomics and healthcare, discusses AI-driven genomic analysis and patient outcome prediction, and addresses the challenges and ethical considerations of integrating AI into genomics.
Inclusive genomics: A path to equitable precision medicine
In this whitepaper, we delve into the critical role of diversity, equity, and inclusion (DEI) in genomic research, addressing how these principles not only enhance scientific rigour but also ensure equitable health benefits.
Precision in practice: Harnessing polygenic risk scores for targeted metabolic dysfunction-associated steatohepatitis (MASH) therapies
In this whitepaper, we explore how polygenic risk scores can be harnessed to drive decision-making in MASH management, offering new avenues for early prediction, precise diagnosis, and tailored treatment strategies.
Strategic approaches for building effective clinical trial recruitment channels
This whitepaper explores proven recruitment strategies, meaningful measurement, diversity enhancement, and the utilisation of new technologies to ensure efficient and forward-looking recruitment efforts.
Connecting communities: Engaging patients in registries for long-term impact
This whitepaper maps a path for patient advocacy groups looking to engage their communities through sustainable patient registries.
Unravelling the complexities of genomics-driven drug discovery
In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases.Genetics essentials for clinical research professionals
This guide offers clinical research professionals a comprehensive overview of genetics, covering trends, core concepts, relevant technologies, and applications in drug development, along with additional learning resources.
Trial-enabling protocols for precision medicine clinical development teams
This whitepaper underscores our dedication to supporting success in precision medicine clinical development, addressing trial-enabling protocols, trial design principles, patient voice representation, monitoring the funnel, and other pertinent topics.
The lasting impact of COVID-19 on clinical trials
This whitepaper explores the pivotal shifts in clinical trials during the COVID-19 pandemic, analyses current trends in the sector, and discusses their implications for the future of medical research, including the impact on clinical recruitment and participation.
The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
Get in touch
We’ll respond to you within one working day
Want to see more?
Delve into the details of our work with reports on condition areas, industry trends, and more.
Blog
Gain insights into the current landscape of precision medicine and clinical research.
The Genetics Podcast
Tune in to the #1 genetics podcast for hot topics in biomarker-led drug development.
Whitepapers
Explore the biggest issues facing the precision medicine research industry.
Webinars
Hear from experts on some of the most pressing topics in the precision medicine industry today.